IOMINVESTCOM
09 Feb 2017
Re: Hello gretel Hi Gretel,Thanks for your reply and no worries.During this week I had tried a few dummy trades and as you say 1p seen.Took the plunge and started a position in these ahead of a potential full write-up in SCSW.I guess every time they find a suitable bolt-on acquisition they may look to shareholders to raise the cash for each one so over time able to part take in building up my position based on keeping an eye on SDI progress.atb
gretel
09 Feb 2017
Re: Hello gretel This morning's spread is a mere 1p at 20p-21p - and a 50k sell achieved a premium anyway at 20.25p.Even if the "published" spread is 2p, you can often trade well inside the spread online or via your broker. I never worry about the quoted spread - it's always best to try dummy trades or look at the actual trades to see what the true spread is (not trying to teach you to suck eggs, or however the saying goes!).Worth noting that the SCSW tip this weekend was just a brief Buy idea.It concluded "More in a future issue". Buy", so hopefully there's still a full write-up to come in the next issue.
IOMINVESTCOM
07 Feb 2017
Re: Hello gretel Hi Gretel,Just noticing the spread on these is quite large ie 18 - 20 spread. Over the time recently would you say it normally has a wide spread like this?Thanks
IOMINVESTCOM
06 Feb 2017
Re: Hello gretel Hi Gretel,Yes, SDI caught my eye when reading a bit on them in this weekend's SCSWAlmost put a buy in first thing before they popped higher with wide spread.atb.
gretel
06 Feb 2017
Re: Hello gretel Hi, hope you buy in at a decent price!SDI were tipped as a Buy by the excellent SCSW magazine this Saturday. Given the timing of your post, were you brought here by that tip?
IOMINVESTCOM
04 Feb 2017
Hello gretel I see you have been all alone on the bb following this company. Think I might have to join you...80)
gretel
27 Jan 2017
New article from Private Punter Great article from the Private Punter in the Cambridge News, which lays out all the fundamentals and the potential.On a P/E of 9.9 - and much less if you strip out the cash pile - with new product potential and acquisitions in the pipeline, what more do people need?Here's a direct link:[link]
gretel
24 Jan 2017
Excellent interims today Very solid interim results:[link] an interim PBT of £421,000 SDI are now a sizeable entity. They have cash in the bank, and the outlook for the year is "strong", with the likelihood of more acquisitions.I note that Finncap have left forecasts unchanged at 1.7p EPS "despite the product mix benefits to gross margin reported in these interim results", which suggests some upside to forecasts later in the year.At the current 19.5p a P/E of 11.5 is pretty cheap imho, and even more so if you net out the cash.With "increased interest in ProReveal" in the UK following the new guidelines and sales in the USA there's an opportunity for a decent boost to turnover and profits from this product.The Chairman's comments are very positive:"Ken Ford, Chairman of SDI, commented: "It has been a positive performance in the first half of the year, and the outlook for the full year is strong. SDI now has a growing portfolio of profitable businesses which are providing the Group with increased and sustained profitability. We have been particularly pleased with the performance of Sentek, the manufacturer of electrochemical sensors that we acquired in October 2015, and we will continue to grow as we seek to diversify our existing product range and widen our addressable market.'"
gretel
19 Jan 2017
RNS : Oryx increase to 9.4% The shareholder list here gets even more ridiculously heavyweight today, with Oryx buying almost another 3.9m shares and increasing to 8.35m, or 9.4%:[link]
gretel
12 Jan 2017
RNS:Octopus buy another 1.15m shares Octopus Investments have increased their holding by just over 1.15m shares. They now hold 8.86m shares, or 9.97%:[link]
gretel
11 Jan 2017
RNS : new holder buys 12% of SDI Today's RNS states that the Business Growth Fund have bought 12% of SDI, or 10.77m shares.The Fund will have picked up almost half of the placing shares as they weren't a major shareholder before.Quite a vote of confidence in this still micro-cap company. And it makes the shareholder list even more blue chip than it already was 
))[link]
gretel
10 Jan 2017
Director buying, acq'n approved Good to see the Astles acquisition approved - and the Chairman and CEO buying £32,000 and £10,000 more shares respectively (even if it was at 13p - sob!)[link]
gretel
09 Jan 2017
Exciting news re ProReveal ProReveal is essentially in the price for free given the low P/E and sound Balance Sheet:[link] 6th January, 2017MHRA registrationSynoptics Limited, an expert in scientific imaging products, is pleased to announce that the ProReveal fluorescence protein detection test system has been registered with the MHRA as a medical device, and now conforms to the latest HTM-01-01 changes introduced in July 2016.ProReveal was developed in conjunction with Queen Mary University of London with the help of Professor David Perrett, and has been designed as a more effective method of ensuring the cleanliness of reprocessed surgical instruments. The UK Department of Health changed their guidelines (HTM-01-01) which now require a quantitative method of measuring the residual protein present after the washing process. ProReveal is able to detect a single spot of residual protein as low as 50ng and shows where protein is located on the surface of a surgical instrument and how much.Guy Fiddian, Sales Manager of Synoptics Health says ‘This is a great step forward for the ProReveal system to access all UK SSDs. The high risk, neurosurgical units are required to comply by July 2017, and the rest by July 2018. Now that the ProReveal is compliant, potential customers can be reassured that the ProReveal will fully meet their protein detection requirements.’Brian Stammers, CEO of Synoptics Limited says ‘We are happy that the ProReveal can assist in making SSD environments HTM-01-01 compliant and help reduce risk and improve patient safety.’"
gretel
28 Dec 2016
Finncap's forecast very conservative? Interesting to see how conservative Finncap have been regarding the new Astles acquisition.In particular, for next year to May'18 they go for 1.9p EPS. This incorporates an additional £1.34m gross profit and £0.59m PBT from Astles.Yet Astles' track record is as follows: y/e 30/4/17 (forecast) - £1.66m gross profit, £0.96m PBT y/e 30/4/16 - £1.50m gross profit, £0.88m PBT y/e 30/4/15 - £1.31m gross profit, £0.75m PBT y/e 30/4/14 - £1.08m gross profit, £0.56m PBT y/e 30/4/13 - £1.11m gross profit, £0.59m PBT y/e 30/4/12 - £0.74m gross profit, £0.34m PBT y/e 30/4/11 - £0.62m gross profit, £0.32m PBTThis implies Finncap are utilising Astles' results from 2014/15 - even if Astles only repeat the current year's results there may be some £400,000 of additional PBT on top of that in the forecasts.
gretel
22 Dec 2016
Moving up, looking good online Looking very good online. You can sell 80,000 at 17p, but only buy a measly 10k at the full 19p offer.The 2p published spread is not bad at all by SDI's standards, and you can actually sell smaller amounts at a big premium at 17.65p, so the real spread is actually a lot less than you might think.
